0

    526546

    CHOKSILA

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    CHOKSI LABORATORIES LTD. Share Price Today

    Investment Returns

    Over 1 Month -3.11% Over 3 Months 18.61% Over 6 Months 1.67% Over 1 Year -40.72%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    CHOKSI LABORATORIES LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 82.30
    • P/E Ratio (TTM) 41.91
    • Beta 0.49
    • Book Value / share 36.71
    • Return on equity 6.63%
    • EPS (TTM) 2.16
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 1.03
    info icon alternate text

    CHOKSI LABORATORIES LTD. Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 12.82
    Operating Expense 11.78
    Net Profit 1.03
    Net Profit Margin (%) 8.03
    Earnings Per Share (EPS) 1.47
    EBITDA 3.70
    Effective Tax Rate (%) 6.36
    Particulars DEC 2025 (Values in Cr)
    Revenue 10.82
    Operating Expense 10.81
    Net Profit 0.31
    Net Profit Margin (%) 2.86
    Earnings Per Share (EPS) 0.45
    EBITDA 3.54
    Effective Tax Rate (%) 65.55
    Particulars SEP 2025 (Values in Cr)
    Revenue 11.12
    Operating Expense 10.57
    Net Profit 0.24
    Net Profit Margin (%) 2.15
    Earnings Per Share (EPS) 0.35
    EBITDA 2.94
    Effective Tax Rate (%) 57.14
    Particulars JUN 2025 (Values in Cr)
    Revenue 11.24
    Operating Expense 10.62
    Net Profit 0.39
    Net Profit Margin (%) 3.46
    Earnings Per Share (EPS) 0.55
    EBITDA 2.91
    Effective Tax Rate (%) 38.09
    Particulars MAR 2025 (Values in Cr)
    Revenue 11.40
    Operating Expense 10.18
    Net Profit 0.92
    Net Profit Margin (%) 8.07
    Earnings Per Share (EPS) 1.32
    EBITDA 3.54
    Effective Tax Rate (%) 26.98
    Particulars MAR 2026 (Values in Cr)
    Revenue 46.01
    Operating Expense 43.78
    Net Profit 1.96
    Net Profit Margin (%) 4.25
    Earnings Per Share (EPS) 2.82
    EBITDA 13.10
    Effective Tax Rate (%) 38.55
    Particulars MAR 2025 (Values in Cr)
    Revenue 41.78
    Operating Expense 39.69
    Net Profit 1.52
    Net Profit Margin (%) 3.63
    Earnings Per Share (EPS) 2.19
    EBITDA 11.30
    Effective Tax Rate (%) 29.30
    Particulars MAR 2024 (Values in Cr)
    Revenue 36.70
    Operating Expense 35.19
    Net Profit 1.11
    Net Profit Margin (%) 3.02
    Earnings Per Share (EPS) 1.59
    EBITDA 10.37
    Effective Tax Rate (%) 33.13
    Particulars MAR 2023 (Values in Cr)
    Revenue 34.44
    Operating Expense 33.19
    Net Profit 3.21
    Net Profit Margin (%) 9.32
    Earnings Per Share (EPS) 4.61
    EBITDA 12.71
    Effective Tax Rate (%) 13.70
    Particulars MAR 2022 (Values in Cr)
    Revenue 30.04
    Operating Expense 29.80
    Net Profit 0.21
    Net Profit Margin (%) 0.69
    Earnings Per Share (EPS) 0.30
    EBITDA 9.01
    Effective Tax Rate (%) 43.24
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 33.89
    ROE % 6.63
    ROCE % 8.89
    Total Debt to Total Equity 1.31
    EBITDA Margin 27.21
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 31.89
    ROE % 5.12
    ROCE % 8.58
    Total Debt to Total Equity 1.46
    EBITDA Margin 28.45
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 30.31
    ROE % 8.41
    ROCE % 8.92
    Total Debt to Total Equity 1.79
    EBITDA Margin 30.43
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 25.70
    ROE % 1.18
    ROCE % 6.29
    Total Debt to Total Equity 2.14
    EBITDA Margin 30.03
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 25.48
    ROE % -13.74
    ROCE % 0.02
    Total Debt to Total Equity 1.86
    EBITDA Margin 17.94
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.61
    Total Assets 65.33
    Total Liabilities 65.33
    Total Equity 23.60
    Share Outstanding 0
    Price to Book Ratio 3.55
    Return on Assets (%) 2.33
    Return on Capital (%) 2.95
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.65
    Total Assets 61.95
    Total Liabilities 61.95
    Total Equity 22.21
    Share Outstanding 0
    Price to Book Ratio 1.33
    Return on Assets (%) 1.79
    Return on Capital (%) 2.16
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.33
    Total Assets 60.36
    Total Liabilities 60.36
    Total Equity 21.10
    Share Outstanding 0
    Price to Book Ratio 1.10
    Return on Assets (%) 5.31
    Return on Capital (%) 6.24
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.40
    Total Assets 64.41
    Total Liabilities 64.41
    Total Equity 17.90
    Share Outstanding 0
    Price to Book Ratio 0.99
    Return on Assets (%) 0.32
    Return on Capital (%) 0.39
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.30
    Total Assets 66.38
    Total Liabilities 66.38
    Total Equity 17.74
    Share Outstanding 0
    Price to Book Ratio 0.31
    Return on Assets (%) -3.92
    Return on Capital (%) -4.83
    Particulars MAR 2025 (Values in Cr)
    Net Income 2.15
    Cash from Operations 13.77
    Cash from Investing -7.60
    Cash from Financing -4.21
    Net change in Cash -0.04
    Free Cash Flow 21.21
    Particulars MAR 2024 (Values in Cr)
    Net Income 1.66
    Cash from Operations 12.04
    Cash from Investing -6.64
    Cash from Financing -4.58
    Net change in Cash 0.31
    Free Cash Flow 16.39
    Particulars MAR 2023 (Values in Cr)
    Net Income 3.72
    Cash from Operations 7.50
    Cash from Investing -0.70
    Cash from Financing -7.61
    Net change in Cash -0.06
    Free Cash Flow 11.44
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.36
    Cash from Operations 6.70
    Cash from Investing -2.70
    Cash from Financing -5.06
    Net change in Cash 0.10
    Free Cash Flow 7.68
    Particulars MAR 2021 (Values in Cr)
    Net Income -2.80
    Cash from Operations 2.78
    Cash from Investing -7.64
    Cash from Financing 1.62
    Net change in Cash -0.11
    Free Cash Flow 10.33
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8980.50 69.09 13.62 129125.81 6680.00 9326.80
    FORTIS MALAR HOSPITALS LIMITED 49.16 0.00 2.68 92.13 40.75 76.00
    SHREE PACETRONIX LTD. 147.00 17.54 3.09 55.12 90.00 283.15
    TRANSGENE BIOTEK LTD. 2.91 0.00 2.63 22.05 1.83 5.17
    VIMTA LABS LIMITED 478.55 35.16 6.23 2137.65 377.30 902.85
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8980.50 91.79 12.96 129125.81 6680.00 9326.80
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 38.95 0.00 -9.47 29.10 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5847.45 25.99 4.84 6397.11 5010.00 6725.00

    CHOKSI LABORATORIES LTD. shareholding pattern

    Holding
    61.5%
    31.48%
    7.01%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    CHOKSI LABORATORIES LTD. Technicals Summary

    118.20 0.00 redarrow
    red-green-graph indicator
    5 Bearish
    11 Bullish
    • 5 Days 118.90
    • 26 Days 117.10
    • 10 Days 117.80
    • 50 Days 116.60
    • 12 Days 117.50
    • 100 Days 116.80
    • 20 Days 117.10
    • 200 Days 121.00
    121.32 PIVOT
    First Support 114.63 First Resistance 124.88 Second Support 111.07 Second Resistance 131.57 Third Support 104.38 Third Resistance 135.13
    RSI 51.68 ADX 71.41 MACD 0.36 Williams % R -46.97 Commodity Channel Index (CCI) 29.57
    Date 2026-08-07 Week 3250.00 Same Day 863.00 Month 1785.00
    1 Year 0.49 3 Year 0.80
    Over 1 Month
    -3.11% down
    Over 1 Year
    -40.72% down
    Over 3 Months
    18.61% down
    Over 3 Years
    26.34% down
    Over 6 Months
    1.67% down
    Over 5 Years
    43.46% down

    CHOKSI LABORATORIES LTD. Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Choksi Laboratories Ltd?

    Answer Field

    Choksi Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 118.20 as on Aug 07 2026 02:02 PM.

    What is the Market Cap of Choksi Laboratories Ltd Share?

    Answer Field

    The market cap of Choksi Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 82.30 as on Aug 07 2026 02:02 PM.

    What is the 52 Week High and Low of Choksi Laboratories Ltd?

    Answer Field

    The 52 Week High and Low of Choksi Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 236.70 and ₹ 81.85.

    What is 1 year return for Choksi Laboratories Ltd?

    Answer Field

    The 1 year returns on the stock has been -40.72%.

    What is the P/E Ratio of Choksi Laboratories Ltd Share?

    Answer Field

    As on Aug 07 2026 02:02 PM the price-to-earnings (PE) ratio for Choksi Laboratories Ltd share is 41.91.

    What is the PB ratio of Choksi Laboratories Ltd Share?

    Answer Field

    As on Aug 07 2026 02:02 PM, the price-to-book (PB) ratio for Choksi Laboratories Ltd share is 36.71.

    How to Buy Choksi Laboratories Ltd Share?

    Answer Field

    You can trade in Choksi Laboratories Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Choksi Laboratories Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Choksi Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Choksi Laboratories Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |